Article info

Download PDFPDF

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

Authors

  1. Correspondence to Dr Thomas A Ciulla, Indiana University School of Medicine, Indianapolis, Indiana, USA; thomasciulla{at}gmail.com
View Full Text

Citation

Ciulla TA, Pollack JS, Williams DF
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

Publication history

  • Received January 23, 2020
  • Revised March 17, 2020
  • Accepted March 19, 2020
  • First published April 7, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.